📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
64 announcements match the current filters (relevance ≥ 5).
Aster DM Receives NCLT Order to Convene Meetings for Merger with Quality Care India
Aster DM Healthcare has received an NCLT order to convene meetings for shareholders and unsecured creditors between February 27 and March 13, 2026, to approve its merger with Quality Care India Limited (QCIL). The combined entity, Aster DM Quality Care, will become one of India's top three hospital chains with a total capacity of over 10,360 beds. The merger has already secured CCI and Stock Exchange approvals and is expected to be completed by Q1 FY27. This consolidation, backed by Blackstone, aims to scale capacity to over 14,715 beds in the coming years.
Key Highlights
NCLT directed shareholder and creditor meetings to be held between Feb 27 and March 13, 2026
Merged entity will have 10,360+ beds, positioning it as one of India's top 3 hospital chains
Transaction has already received CCI and Stock Exchange approvals with Q1 FY27 completion target
Combined portfolio to include four major brands: Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare
Long-term growth strategy aims to expand total bed capacity to approximately 14,715+ beds
👀 What to Watch
Investors should monitor the upcoming shareholder meetings in March 2026 as this merger significantly enhances the company's scale and market position. The entry of Blackstone as a co-promoter and the massive bed expansion plan are strong long-term value drivers.
Aster DM Receives NCLT Order to Convene Shareholder Meeting for Quality Care Merger
The NCLT Hyderabad Bench has directed Aster DM Healthcare to convene meetings for equity shareholders and unsecured trade creditors between February 27 and March 13, 2026, to approve its merger with Quality Care India Limited. This amalgamation is expected to create one of India's top three hospital chains, significantly expanding the footprint to 9 states and 25 cities. Management anticipates the merger will be accretive to both Earnings Per Share (EPS) and EBITDA margins. The tribunal has dispensed with the requirement for a meeting of secured creditors, streamlining the approval process.
Key Highlights
NCLT directed shareholder and unsecured creditor meetings to be held between Feb 27 and March 13, 2026.
The merger aims to position the combined entity among the top 3 hospital chains in India with presence in 25 cities.
Aster DM's paid-up share capital as of Sept 30, 2025, stands at ₹518.12 crore across 51.81 crore equity shares.
Quality Care India Limited has a paid-up share capital of ₹380.92 crore and operates multi-specialty hospitals in India and Bangladesh.
Management expects the deal to be financially accretive to EPS and EBITDA margins for existing shareholders.
👀 What to Watch
Investors should vote in favor of the merger during the upcoming March 2026 meeting as it provides significant scale and financial synergies. Monitor the post-merger integration plan and updated guidance on EPS accretion following the shareholder approval.
Aster DM Healthcare Increases Stake in Prerana Hospital to 98.92% for ₹38.36 Crore
Aster DM Healthcare has acquired an additional 11.94% stake in its subsidiary, Prerana Hospital Limited, for a cash consideration of ₹38.36 crore. This transaction increases Aster's total shareholding from 87% to 98.92%, moving closer to making it a wholly-owned subsidiary. Prerana Hospital has shown strong growth, with turnover rising from ₹98.92 crore in FY23 to ₹145.05 crore in FY25. The company expects to acquire the remaining 1.08% stake by December 31, 2026.
Key Highlights
Acquired 11.94% additional equity stake in Prerana Hospital Limited for ₹38.36 crore
Total shareholding in the subsidiary increased from 87% to 98.92%
Prerana Hospital reported a turnover of ₹145.05 crore for FY 2024-25
Target entity turnover has grown at a CAGR of approximately 21% over the last two years
Final 1.08% stake acquisition scheduled for completion by December 31, 2026
👀 What to Watch
Investors should view this as a positive consolidation of a growing healthcare asset that strengthens Aster's portfolio. No immediate action is required, but the hospital's improving revenue trend is a good sign for long-term value.
Aster DM Clarifies ₹125 Crore Kerala Project Status Pending Board Approvals
Aster DM Healthcare has issued a clarification regarding its previously announced ₹125 crore healthcare development project in Kottakkal, Kerala. The company specified that the project is currently a proposal and remains subject to formal approvals from the Board of Directors of both Aster DM and its subsidiary, Malabar Institute of Medical Sciences Limited. While the investment size is significant, the project is not yet finalized. The company has committed to making further disclosures once the requisite corporate approvals are obtained.
Key Highlights
Proposed ₹125 crore healthcare development project in Kottakkal, Kerala
Project requires formal approval from the Board of Directors of Aster DM Healthcare
Approval also pending from subsidiary Malabar Institute of Medical Sciences Limited
Clarification issued following a media release dated December 18, 2025
👀 What to Watch
Investors should treat the expansion as a proposed plan rather than a finalized commitment until board approvals are confirmed. Monitor future regulatory filings for the official commencement of the project.
